The Role of p66Shc in Cancer: Molecular Mechanisms and Therapeutic Implications
Journal of Cellular and Molecular Medicine · 2025-07 · 29 (14)
DOI: 10.1111/jcmm.70737 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 21.07.2025. Verfasst von Davood Zaeifi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Src Homology 2 Domain-Containing, Transforming Protein 1, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
p66Shc is a redox‐sensitive and pro‐apoptotic adaptor protein that regulates oxidative stress and mitochondrial apoptosis. It is the largest of three isoforms encoded by the proto‐oncogene ShcA (Src collagen homologue A). Members of the ShcA family are capable of recruiting various signalling molecules and are involved in several cellular pathways, including proliferation, growth and survival. Increasing evidence highlights the p66Shc role in various tumourigenic processes, such as cell expansion, progression, metastasis and metabolic reprogramming. This review summarises current knowledge on the role of p66Shc in cancer, explains the molecular mechanisms underlying the effects of this protein, and considers therapeutic prospects aimed at targeting it. Emerging therapeutic strategies, including small‐molecule inhibitors and gene‐editing approaches, are discussed alongside challenges in clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Pharmaceutical Research Center, Institute of Pharmaceutical Technology, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad, Iran.
ORCID-Profile: Gholamreza Karimi
Zitieren
APA
Zaeifi, D., Jamialahmadi, K., & Karimi, G. (2025). The Role of p66Shc in Cancer: Molecular Mechanisms and Therapeutic Implications. Journal of Cellular and Molecular Medicine, 29(14). https://doi.org/10.1111/jcmm.70737
Vancouver
Zaeifi D, Jamialahmadi K, Karimi G. The Role of p66Shc in Cancer: Molecular Mechanisms and Therapeutic Implications. Journal of Cellular and Molecular Medicine. 2025;29(14). doi:10.1111/jcmm.70737
BibTeX
@article{Zaeifi2025,
author = {Zaeifi, Davood and Jamialahmadi, Khadijeh and Karimi, Gholamreza},
title = {The Role of p66Shc in Cancer: Molecular Mechanisms and Therapeutic Implications},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {14},
doi = {10.1111/jcmm.70737}
}
EUVIMED